Sign in to continue:

Saturday, July 25th, 2026

RTX Corporation 2026 Q2 10-Q Report: Financial Performance, Business Segments, and Market Risk Overview




RTX Corporation Q2 2026 Earnings Report: Key Takeaways for Investors

RTX Corporation Q2 2026 Earnings Report: Key Takeaways for Investors

Overview

RTX Corporation (NYSE: RTX), a major player in the aerospace and defense sector, has released its Form 10-Q quarterly report for the period ended June 30, 2026. The report covers detailed financial statements, management’s discussion and analysis, risk factors, and other disclosures relevant to shareholders and market watchers.

Key Highlights

  • Strong Compliance and Full Reporting: RTX confirms it has filed all required reports under the Securities Exchange Act of 1934 and has been subject to such filing requirements for the past 90 days. The company has also submitted all mandatory Interactive Data Files as required by the SEC, signaling robust compliance and transparency.
  • Securities Information:

    • RTX’s common stock (\$1 par value) is actively traded on the New York Stock Exchange under the symbol “RTX”.
    • Additional securities, including the 2.150% Notes due 2030 (CUSIP 75513E AB7), are also listed and traded on the NYSE under the symbol “RTX 30”.
    • As of June 30, 2026, there were 1,347,758,144 shares of common stock outstanding.
  • Large Accelerated Filer Status: RTX is classified as a “Large Accelerated Filer” under SEC rules, indicating a significant market capitalization and high investor interest.
  • Not a Shell Company or Emerging Growth Company: RTX is neither a shell company nor an emerging growth company, reflecting maturity and an established operating history.

Financial Reporting and Structure

  • Quarterly Report Content: The Form 10-Q includes the following major sections for the quarter ended June 30, 2026:

    • Condensed Consolidated Statement of Operations (unaudited)
    • Condensed Consolidated Statement of Comprehensive Income
    • Condensed Consolidated Balance Sheet as of June 30, 2026, and December 31, 2025
    • Condensed Consolidated Statement of Cash Flows for the six months ended June 30, 2026
    • Notes to Condensed Consolidated Financial Statements
    • Report of Independent Registered Public Accounting Firm
  • Management’s Discussion and Analysis (MD&A): The report contains the MD&A section, which provides insight into the company’s financial condition, results of operations, market risks, controls, and procedures.
  • Legal Proceedings and Risk Factors: RTX discloses ongoing legal proceedings and offers an updated assessment of risk factors that could potentially affect the company’s financial health and share price. The legal and compliance disclosures may be particularly relevant to investors seeking to assess any contingent liabilities or regulatory risks.
  • Segment Information: The report includes detailed segment information, with RTX’s primary business segments being Collins Aerospace, Pratt & Whitney, and Raytheon. The performance of these segments is crucial for investors, as shifts in government contracts, commercial aerospace cycles, or defense spending can significantly affect future earnings.
  • Geographical and Customer Concentration: The company provides breakdowns by geographical region (U.S., Europe, Asia-Pacific, Middle East & North Africa, and Other Geographic Regions) and major customers, which is important for understanding market exposure and risks.

Potentially Price-Sensitive Information

  • Outstanding Common Shares: A high number of outstanding shares (over 1.3 billion) can affect EPS (earnings per share) calculations and may be relevant to valuation models.
  • Debt Instruments: RTX’s 2.150% Notes due 2030 and other debt securities are actively traded and listed, with detailed information about their issuance and maturities. Any changes in debt structure, refinancing, or ratings actions could impact share and bond prices.
  • Ongoing Legal Matters and Risk Factors: While the report references disclosure of legal proceedings and risk factors, any material new developments (not fully detailed in the provided excerpt) could influence the share price depending on the scale and potential liability.
  • Segment and Geographic Performance: Investors are encouraged to review the segment and regional breakdowns as shifts in performance or exposure to conflict regions, regulatory changes, or macroeconomic conditions could materially impact future results.
  • No Indication of Restatement or Transition Filing: There is no indication of restated financials or transition reports, which reassures investors of the continuity and reliability of RTX’s reporting.

What Shareholders Should Watch

  • Upcoming Financial Results: The condensed consolidated financial statements, MD&A, and notes—once examined in detail—will be critical for assessing RTX’s near-term prospects, especially in the context of global aerospace and defense demand, supply chain stability, and government spending.
  • Legal and Regulatory Disclosures: Shareholders should closely monitor any notes about litigation, regulatory actions, or contingent liabilities, as these could have near- to medium-term impacts on valuation.
  • Market and Operating Risks: The company’s exposure to various regions and customer concentration, as well as its debt structure, should be reviewed to evaluate potential vulnerabilities or growth opportunities.

Conclusion

RTX Corporation’s Q2 2026 10-Q filing affirms a stable, mature reporting entity with robust compliance, a diversified product and segment mix, and active securities listings on the NYSE. While the report does not disclose any immediate “shock” events or restatements, investors should examine the details of the financial statements, risk disclosures, segment results, and legal proceedings for potential early signals of earnings momentum or headwinds.

Any material developments in these areas could have a significant impact on RTX’s share price and overall market perception.


Disclaimer: This article is intended for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors are encouraged to review RTX Corporation’s full SEC filings and consult with a qualified financial advisor before making investment decisions.




View RTX Corp Historical chart here



Evofem Biosciences, Inc. 2025 Annual Report: Business Overview, Financials, and Risk Factors (Form 10-K)

Evofem Biosciences, Inc. 2025 Annual Financial Report: Key H...

TEGNA Inc. Completes Merger with Nexstar Media Group – SEC Form 8-K Filing Details

TEGNA Inc. 8-K Filing: Shareholder & Investor Update T...